We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Peel-and-Sniff Cards Could Make Smell Test Single Best Predictor of Being COVID-19 Positive

By LabMedica International staff writers
Posted on 14 Oct 2020
Sensory scientists are encouraging smell checks to fight the COVID-19 spread and are also developing peel-and-sniff cards to supplement other COVID-19 testing and surveillance efforts.

With mounting scientific evidence that anosmia, or loss of smell, is one of the most specific symptoms of COVID-19 infection, sensory scientists at the Pennsylvania State University (University Park, PA, USA) are making efforts to raise awareness about the link between COVID-19 and smell loss. More...
Previous research has found that certain cells at the top of the nasal cavity harbor proteins that the coronavirus targets when invading these cells. The local disruption that occurs is different from the loss of smell that occurs with the common cold, which is due to blockage of the nasal passages. With COVID-19, many patients lose the ability to smell without being stuffy or congested.

The sensory scientists at Penn State believe that greater public awareness of the link between COVID-19 and sudden smell loss could assist in identifying pre-symptomatic or otherwise asymptomatic individuals, which might help contain the virus and ease the burden on sometimes-overwhelmed health care facilities. Additionally, the scientists are members of an international research team, the Global Consortium for Chemosensory Research, that has studied the link between COVID-19 and smell loss. Collaborating with more than 600 clinicians, scientists and patient advocates in 40 countries in an ongoing study, the Penn State researchers so far have surveyed more than 40,000 participants who suffered from recent respiratory illness. The scientists are now developing peel-and-sniff cards that will be distributed to the Penn State community in the near future to supplement other COVID-19 testing and surveillance efforts.

"Our results showed that of all common symptoms of COVID-19, sudden smell loss was the single best predictor of being positive for the disease," said John Hayes, professor of food science and director of the Penn State Sensory Evaluation Center. "Other studies are finding similar results. Together, this suggests that sudden smell loss is a better predictor than fever or cough."

Related Links:
Pennsylvania State University


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.